RenovoRx (RNXT) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

RNXT RenovoRx

Watchlist

1.390
+0.090+6.92%

Close Dec 30 16:00 ET

33.36MMarket Cap-2.40P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options
PR NewswireDec 23 10:49 ET
RenovoRx Announces SCRI Oncology Partners Enrolling Patients for Trial
TipRanksDec 11 08:12 ET
Ascendiant Maintains RenovoRx(RNXT.US) With Buy Rating, Raises Target Price to $9
Moomoo NewsDec 10 10:31 ET · Ratings
RenovoRx Is Maintained at Buy by Ascendiant Capital
Dow JonesDec 10 04:31 ET · Ratings
RenovoRx Price Target Raised to $9.00/Share From $8.25 by Ascendiant Capital
Dow JonesDec 10 04:31 ET · Ratings
RenovoRx Analyst Ratings
BenzingaDec 10 04:17 ET · Ratings

Comments

Jaguar8

Dec 11 07:11

NEWS

$RenovoRx (RNXT.US)$
RenovoRx Initiates Patient Enrollment at SCRI Oncology Partners for Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial in Locally Advanced Pancreatic Cancer
11 minutes ago, 5:00 AM PST
Via GlobeNewswire
RNXT
Share
TIGeR-PaC is Evaluating the TAMP™ (Trans-Arterial Micro-Perfusion) Therapy Platform for the Treatment of Locally Advanced Pancreatic Cancer
Dr. Meredith Pelster, Associate Director for GI Research Across Sarah Cannon Research Institute (SCRI), Appointed Princi...

Jaguar8

Dec 5 07:02

NEWS

$RenovoRx (RNXT.US)$
RenovoRx Receives First Purchase Orders for its FDA-Cleared RenovoCath® Delivery System
Thursday, 5th December at 8:00 am
Over Ten Medical Institutions Nationwide have Initiated RenovoCath Purchase Process, Further Accelerating Commercialization Strategy
RenovoRx Estimates Initial Target Market Size for RenovoCath of Several Hundred Million Dollars in Annual Sales
Global Medical Device Commercial Leader, Richard Stark, Joining RNXT as Commercial Advisor
LOS ALTOS, Cal...

MadMaverick_

Nov 21 14:37

$RenovoRx (RNXT.US)$ $Backblaze (BLZE.US)$ $Exact Sciences (EXAS.US)$ $Elevance Health (ELV.US)$
RNXT SMA200 is $1.20, if we can hold above , that's bullish for sure IMO
But always have that protection in place for the profits !
MORE INFO BELOW 👇
https://chartingdaily.com/delivering-therapy-where-it-matters-now
Communicated disclaimer

Trytosaveabit

Nov 20 07:52

Update

$RenovoRx (RNXT.US)$ Northwell Health Cancer Institute Launches Patient Enrollment in Renovorx’s Ongoing Pivotal Phase III Tiger-Pac Clinical Trial

Jaguar8

Nov 20 07:51

NEWS

$RenovoRx (RNXT.US)$
Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx's Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
5 minutes ago, 5:45 AM PST
Via GlobeNewswire
The Northwell Health Cancer Institute is the Most Recent Clinical Site to Join the TIGeR-PaC Study, and RenovoRx Aims to Reach Full Patient Enrollment in the First Half of 2025
Phase III Clinical Trial is Evaluating the TAMP™ (Trans-Arterial Micro-Perfusion) Therapy Platform for the Treatment of Loc...

Trending US Stocks

Symbol Mini Chart % Chg

DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS

Unlock the Full List